Projections for elixia sound fantastic but the valuation for Oxy Patch seems low at 14c. This is based on market share of 15% which i'm sure most here would say is conservative.
Very happy with the exposure from the report but a little concerned that the flagship product has been valued so low.
elixia asia sales $200 mill within 3 yrs, page-43
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.783K | 594.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 96365901 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21872826 | 7 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |